πŸ‡ΊπŸ‡Έ FDA
Patent

US 10188648

Solid state forms of selexipag

granted A61KA61K31/4965A61P

Quick answer

US patent 10188648 (Solid state forms of selexipag) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4965, A61P, A61P9/10, A61P9/12